VaginistisEtiología, diagnóstico y profilasis

  1. Martín Villena, María José 1
  2. Morales Hernández, María Encarnación 1
  3. Clares Naveros, Beatriz 1
  4. Ruiz Martínez, María Adolfina 1
  1. 1 Universidad de Granada
    info

    Universidad de Granada

    Granada, España

    ROR https://ror.org/04njjy449

Aldizkaria:
Ars pharmaceutica

ISSN: 2340-9894,  0004-2927

Argitalpen urtea: 2012

Alea: 53

Zenbakia: 4

Orrialdeak: 32-40

Mota: Artikulua

DIALNET GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Ars pharmaceutica

Laburpena

Vaginitis is one of the most common gynecological problems diagnosed by primary care physicians. In this article we wanted to describe the different types of vaginitis, their symptoms and the different drug treatments. The presence of recurrent episodes and the re-exposure to antibiotics can cause adverse reactions and suggesting the need for alternative treatment. Numerous studies propose the use of probiotics for the treatment of this pathology basing on the regulatory capacity that probiotics have on the vaginal microbiota. This capacity is due to the ability to maintain vaginal pH ≤ 4.5, the production of biosurfactants and blocking adhesion of uropathogens. The fact that the colonization of the genitourinary tract is faster when probiotics are administered vaginally suggesting that this kind of administration could have a lot of advantages.

Erreferentzia bibliografikoak

  • Amsel A, Totten PA, Spiegel Cam Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Mede. 1998; 74:14-22.
  • Aroutcheva A, Gariti D, Simon M, et al. Defense factors of vaginal Lactobacilli. Am J Obstet Gynecol. 2001; 185:375-9.
  • Austin MN, Beigi RH, Meyn LA, Hillier SL. Microbiologic response to trearment of bacterial vaginois with topical clindamycin or metronidazole. J Clin Microbiol. 2005; 43:4492-7.
  • Beigi RH, Austin MN, Meyn LA, Krohn MA, Hilleir SL. Antimicrobial resistnace associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol. 2004; 191:1124- 9.
  • Beigi RH, Meyn LA, Moore DM, Krohn MA, Hillier SL. Vaginal yeast colonization in nonpreganant women: a longitudinal study. Obstet Gynecol. 2004; 104:926-30.
  • Bornstein j, Lakovsky Y, Lavi I, Bar- AM A, Abramocici H. The classis approach to diagnosis of vulvovaginitis: a critical analysis. Infect Dis Obstet Gynecol. 2001; 105-11.
  • Brown HL, Fuller DD, Jasper LT, Davs TE, Wright JD. Clinical evaluation of Affirm VPIII in the detection and identification of Trichomonas Vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. Infect Dis Obstet Gynecol. 2004:10-7.
  • Burtin P, Taddio A, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol. 1995; 172:525-9.
  • Cadiex P, Burton J, Gardiner G, et al. Lactobacillus strains and vaginal ecology. JAMA. 2002; 287:1940-1.
  • Eschenbach DA. Chronic vulvovaginal candidiasis. N Engl J Med. 2004; 351:851-2.
  • Fiscella K, Klebanoff MA. Are racial Differences in vaginal pH explained by vaginal flora? Am J Obstet Gynecol. 2004; 191:747-50.
  • Forsum U, Holst E, Larsson PG, et al. Bacterial vaginosis a microbiological and immunological enigma. APMIS. 2005; 113:543-52.
  • Gardiner GE, Heinemann C, Bruce AW, et al. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. Rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diagn Lab Immunol. 2002; 9:92-6.
  • Gutman RE, Peipert JF, Weitzen S, Blume J. Evaluation of clinical methods for diagnosing bacterial vaginosis. Obstet Gynecol. 2005; 105:551-6.
  • Hammill HA. Normal vaginal flora in relation to vaginitis. Obstet Gynecol Clin North Am. 1989; 16:329-336.
  • Hilton E, Isenberg HD, Alperstein P, Borenstein MT. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxix for cnadidal vaginitis. Ann Intern Med. 1992; 116:353-7.
  • Kane KY, Pierce R. What are the most effective treatments for bacterial vaginosis in nonpregnant women? J Fam Pract. 2001; 50:339-400.
  • Klebanoff MA, Carely JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic trichomonas vaginalis infection. N Eng J Med. 2001; 345:487-93.
  • Kloumans EH, Markowitz LE, Hogan V. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a Synthesis of data. Clin Infect Dis. 2002; 35:5152-72.
  • Mardh PA. The vaginal ecosystem. Am j Obstet Gynecol. 1991; 165:1163-8.
  • Martin Quan, MD. Vaginitis: Meeting the clinical Challenge. Clinical Cornerstone. 2000; 3:36-47.
  • Mastromarino P, Brigidi P, Macchia A, et al. Characterizaion and selection of vaginal lactobacillus strains for the preraprrion of vaginal trablets. J Appl microbial. 2002; 93:884-93.
  • McCue JD. Evaluation and management of vaginitis. An update for primary care practitioners. Arch Intern Med. 1989; 149:565-8.
  • Mclean NW, Rosenstein IJ. Characterization and selection of Lactobacillus species to re-colonise the vaginal of women with recurrent bacterial vaginoisi. J Med Microbiol. 2000; 49:543-52.
  • Morelli L, Zonenenschain , Del Piano M, Cognein p. Utilization of the intestinal trat as a delivery system for urogenital probiotics. J Clin Gastroenterol. 2004; 38:S107-S110.
  • Ness RB, Hillier SL, Kip KE, Soper DE, Stamm CA, McGrefor JA, et al. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol. 2004; 104:761-9.
  • Nishijima K, Shukunami K, Kotsuji F. Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin. Obstet Gynecol. 2004; 104:1106-07.
  • Owen MK, Clenney TL. Management of vaginitis. Am Fam Physician. 2004; 70:2125-32, 2139-40.
  • Peeters M, Piot P. Adhesion of Gardnerella vaginalis to vaginal epithelial cells: variables affecting adhesion and inhibiotion by metronidazole. Genitourin Med. 1985; 61:391-5.
  • Reid G, Beurman D, Heinemann C Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 2001; 185:375-9.
  • Reid G, Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infec. 2002; 4:319-24.
  • Reid G, Charbonneau D, Erb J, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. Fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003; 35:131-4.
  • Riggs MA, Klebanoff MA. Treatrment of vaginal infections to prevent preterm birth: a meta-analysis. Clin Obstet Gynecol. 2004; 47:796-807.
  • Sanchez S, Garcia PJ, Thomas KK, Catlin M, Holmes KK. Intravagianl metronidazole gel versus metronidasole plus nystatin ovules for bacterial vaginosis: a randomized controlled trail. Am J Obstet Gynecol. 2004; 191:1898-1906.
  • Scahff VM, Perez-Stable E, Borchart K. The limited value of Symptoms and sings in the diagnosis of vaginal infections. Arch Intern Med. 1990; 150:1929-33.
  • Sch webke JR, Desmond RA, Oh MK. Predictors of bacterial vaginosis in adolescent women who douche. Sex Transm Dis. 2004; 31:443-6.
  • Sexually transmitted diseases treatment guidelines 2010. Centers for Diseae Control and Prevention. MMWR Recomm Rep 2010; 55(RR-12):1-110. Disponible en: http://www.cdc.gov.
  • Skarin A, Sylwan F. Vaginal lactobacilli inhibiting growth of gardnerella vagianlis, Mobiluncus and other bacterial species cultures grom vaginal constent of women with bacterial vaginosis. Acta Pathol Microbiol Immunol Scand. 1986; 94:399-403.
  • Sobel JD. What´s new in bacterial vaginosis and trichomonas? Infect Dis Clin N Am. 2005:387-406.
  • Soper DE. Taking the guesswork out of diagnosing and managing vaginitis. Contemporary OB/ GYN. 2005; 50:32-9.
  • Swygard H, Miller WC, Kaydos- Daniels SC, Cohen MS, Leone PA, Hobbs MM, et al. Targeted screening for Trichomonis Vaginalis with culture using a two-step method in women presenting for STD evaluation . Sex Transm Dis. 2004; 31:659-64.
  • Velraeds MM, van der Mei HC, ReidG, Busscher HJ. Inhibition of initial adhesion of uropathogen Enterococcus faecalis by biosurgactants from lactobacillus isolates. Appl environ microbial. 1996; 62:1958:63
  • Weir E. Bacetrial vaginosis: more question than answers. Can med Assoc J. 2004; 171:448-501.
  • Zhan g J, Hatch M, Zhang D, Shulman J, Harville E, Thomas AG. Frequency of douching and risk of bacterial vaginosis in African Amderican women. Obstet Gynecol. 2004; 104:756-60.
Datuen iturria: Dialnet